ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
IGEM gets further funding for cancer drugs
April 04, 2019IGEM Therapeutics has received a £750,000 grant from Innovate UK Biomedical Catalyst Primer Award. -
Trastuzumab Tied to Higher Long-Term Risk for Heart Failure
March 21, 2019Compared with chemotherapy alone, trastuzumab is associated with a twofold increased long-term risk for heart failure in breast cancer survivors, according to a study published in the March 1 issue of JACC: Heart Failure. -
Prestige, Cipla unite to sell cancer biosimilar HD201
December 17, 2018HD201 is a mAb biosimilar to Roche’s Herceptin® which is used to treat patients with HER2-overexpressing breast cancer, HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.
Pharma Sources Insight January 2025
